[Skin manifestations of @entity7139 ( XXXX )].

@entity1 @entity7139 @entity137 @entity417 @entity6794 @entity1333 @entity39 @entity1503 @entity854 @entity348 @entity751 @entity4841 @entity221 @entity617
The authors describe three cases of @entity417 with an excess of myeloblasts in the bone marrow ( @entity7139 ), associated with @entity6794 ( @entity6794 ) and @entity1333 . The first @entity1 was an 85-year old @entity1 whose @entity7139 had begun in 1979. In 1985, he developed @entity6794 in the popliteal fossa and on the right heel. Histology confirmed the diagnosis. A direct immunofluorescence test on the biopsy specimen was negative. Apart from the @entity751 , there were no @entity854 . The cutaneous lesions disappeared after 7 weeks of treatment with @entity617 20 mg per day. The @entity1503 remained unchanged. The second @entity1 was a 71-year old @entity1 with @entity7139 since 1982. In 1984, she presented with lesions of @entity1333 located on the anterior aspect of the upper third of her left leg. There was neither @entity4841 nor @entity221 , and no history of @entity137 . Beside @entity7139 , polyclonal hyperglobulinaemia was present. Histological examination of the skin showed evidence of @entity1333 with @entity39 of vascular walls and perivascular lympho-histiocytic infiltrate with granulocytes and @entity348 . Direct immunofluorescence testing of the skin demonstrated intravascular complement deposits. There were no circulating immune complexes; measurements of complement and complement fractions gave normal values; no cryoglobulin was found. The cutaneous lesions recurred on two occasions in 6 months, although no @entity137 could be elicited and the @entity751 was unaffected. The third @entity1 was a 67-year old @entity1 with @entity7139 since 1982. In 1983, an ulcero-necrotic lesion spontaneously developed on his right leg.(ABSTRACT TRUNCATED AT 250 WORDS)
